Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Tuberculosis Vaccination Recommendations

General Recommendations

  • The primary strategy for preventing and controlling TB in the United States is minimizing transmission risk through early identification and treatment of patients with active infectious TB 3
  • The second most important strategy is identifying persons with latent M. tuberculosis infection and providing preventive therapy with isoniazid or rifampin 3
  • BCG vaccination is not recommended for inclusion in routine immunization or TB control programs in the United States 2
  • BCG vaccine use has been limited because its effectiveness in preventing infectious forms of TB is uncertain and post-vaccination tuberculin reactivity interferes with TB infection diagnosis 4

Specific Recommendations for BCG Vaccination

  • BCG vaccination should be considered for infants and children who reside in settings with high likelihood of M. tuberculosis transmission and subsequent infection 5
  • BCG vaccination should be considered for infants and children who cannot be removed from the source of infection 5
  • BCG vaccination should be considered for infants and children who have no other protective measures that can be implemented 1
  • Specific indications include children who cannot be separated from adults with untreated or ineffectively treated infectious TB 6
  • Specific indications include children who are continually exposed to persons with infectious TB caused by M. tuberculosis strains resistant to both isoniazid and rifampin 6
  • BCG vaccination is not recommended for children infected with HIV due to potential adverse reactions 2
  • BCG vaccination of healthcare workers should be considered only on an individual basis in settings where a high percentage of TB patients are infected with M. tuberculosis strains resistant to both isoniazid and rifampin 7
  • BCG vaccination should not be used as a primary strategy for healthcare workers because the protective efficacy in healthcare workers is uncertain 9
  • The preferred strategies for TB prevention in healthcare facilities are comprehensive infection-control measures, regular tuberculin skin testing to identify newly infected healthcare workers, and preventive therapy when indicated 8
  • BCG vaccination is not recommended for healthcare workers who are infected with HIV or otherwise immunocompromised 8

Effectiveness of BCG Vaccination

  • Meta-analyses have confirmed that BCG provides high protective efficacy (>80%) against serious forms of TB in children, including tuberculous meningitis and disseminated TB 2
  • The protective efficacy for preventing pulmonary TB in adolescents and adults is variable and equivocal 2

Important Considerations

  • TB preventive therapy should be considered for any BCG-vaccinated person with a tuberculin skin-test reaction ≥10 mm of induration, especially if they are a contact of a person with infectious TB 10
  • TB preventive therapy should be considered for any BCG-vaccinated person with a tuberculin skin-test reaction ≥10 mm of induration, especially if they were born or resided in a high TB prevalence country 10
  • TB preventive therapy should be considered for any BCG-vaccinated person with a tuberculin skin-test reaction ≥10 mm of induration, especially if they are continually exposed to high-prevalence populations 10
  • Physicians considering BCG vaccine for their patients should consult with local TB control programs 2

REFERENCES